Literature DB >> 23471023

Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria.

J D Hamilton1, S Ahmed, V C Sandulache, S P Daram, T J Ow, H D Skinner, A Rao, L E Ginsberg, A J Kumar, J N Myers.   

Abstract

BACKGROUND AND
PURPOSE: Criteria for detection of persistent nodal metastases in treated oropharyngeal tumors are sensitive but nonspecific, leading to unnecessary nodal dissections. Developing specific imaging criteria for persistent nodal metastases could improve diagnosis while decreasing patient morbidity.
MATERIALS AND METHODS: Patients with oropharyngeal squamous cell carcinoma with nodal metastases treated by definitive radiation therapy and subsequent nodal dissection were retrospectively evaluated. One hundred thirty-eight patients had pre- and posttherapy contrast-enhanced CTs evaluated by radiologists blinded to the status of pathologically proved hemineck persistent nodal metastases. Composite scoring criteria for CT, combined from individual parameters, were compared with radiologists' opinions, previous multiparameter criteria, and outcome data.
RESULTS: New low-attenuation areas and a lack of size change (<20% cross sectional area) were both highly specific for persistent nodal metastases (99%; P = .0004). Extranodal disease on pretherapy imaging was moderately specific (86%; P = .001). The CSC correctly placed 29 patients in a low-risk category compared with 14 by previously reported criteria and radiologist reports. With good second-rater reliability, the CSC cutoff values stratified patients at highest risk of persistent nodal metastases, thereby improving specificity while maintaining sensitivity.
CONCLUSIONS: Comparing pre- and posttherapy examinations improves specificity by discriminating focal findings and size change compared with a single time point. The CSC can categorize the risk of persistent nodal metastases more accurately than previous CT methods. This finding has the potential to improve resource use and reduce surgical morbidity.

Entities:  

Mesh:

Year:  2013        PMID: 23471023      PMCID: PMC3939678          DOI: 10.3174/ajnr.A3461

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy.

Authors:  Hiroya Ojiri; Anthony A Mancuso; William M Mendenhall; Scott P Stringer
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

2.  Definitive radiotherapy for squamous cell carcinoma of the base of tongue.

Authors:  William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; John W Werning; Douglas B Villaret
Journal:  Am J Clin Oncol       Date:  2006-02       Impact factor: 2.339

3.  The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.

Authors:  Sébastien Clavel; Marie-Pierre Charron; Manon Bélair; Guila Delouya; Bernard Fortin; Philippe Després; Denis Soulières; Edith Filion; Louis Guertin; Phuc Felix Nguyen-Tan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-09       Impact factor: 7.038

4.  Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.

Authors:  T S Boyd; P M Harari; S P Tannehill; M C Voytovich; G K Hartig; C N Ford; R L Foote; B H Campbell; C J Schultz
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

5.  Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

Authors:  R J Wong; D T Lin; H Schöder; S G Patel; M Gonen; S Wolden; D G Pfister; J P Shah; S M Larson; D H Kraus
Journal:  J Clin Oncol       Date:  2002-10-15       Impact factor: 44.544

6.  Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?

Authors:  K Narayan; C H Crane; S Kleid; P G Hughes; L J Peters
Journal:  Head Neck       Date:  1999-10       Impact factor: 3.147

7.  The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease.

Authors:  G L Clayman; C J Johnson ; W Morrison; L Ginsberg; S M Lippman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-02

8.  Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma.

Authors:  Hiroya Ojiri; William M Mendenhall; Scott P Stringer; Patches L Johnson; Anthony A Mancuso
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

9.  Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy?

Authors:  Ilana Doweck; K Thomas Robbins; William M Mendenhall; Russell W Hinerman; Christopher Morris; Robert Amdur
Journal:  Head Neck       Date:  2003-11       Impact factor: 3.147

10.  Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?

Authors:  John W Rogers; Kathryn M Greven; W Frederick McGuirt; John W Keyes; Dan W Williams; Nat E Watson; Kim Geisinger; James O Cappellari
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

View more
  4 in total

1.  Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.

Authors:  Mehdi Taghipour; Esther Mena; Matthew J Kruse; Sara Sheikhbahaei; Rathan M Subramaniam
Journal:  Nucl Med Commun       Date:  2017-03       Impact factor: 1.690

2.  Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.

Authors:  Chad Tang; Clifton D Fuller; Adam S Garden; Musaddiq J Awan; Rivka R Colen; William H Morrison; Steven J Frank; Beth M Beadle; Jack Phan; Erich M Sturgis; Mark E Zafereo; Randal S Weber; David I Rosenthal; G Brandon Gunn
Journal:  Oral Oncol       Date:  2014-11-28       Impact factor: 5.337

3.  CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.

Authors:  Daan Nevens; Olivier Vantomme; Annouschka Laenen; Robert Hermans; Sandra Nuyts
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

4.  The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.

Authors:  Daan Nevens; Olivier Vantomme; Annouschka Laenen; Robert Hermans; Sandra Nuyts
Journal:  Cancer Imaging       Date:  2017-02-28       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.